basq2 ccb2
Name
bgnd2
Label
Biguanides (SHHS2)
Description

Participant taking BIGUANIDES within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
BGND2
Biguanides (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No - 3,461 -
Yes - 159 -
Unknown 5,804 460 5,042
Biguanides (SHHS2) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No - - - - -
Yes - - - - -
Unknown 1,451 1,451 1,451 1,451 5,804
Biguanides (SHHS2) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No - - -
Yes - - -
Unknown 3,039 2,765 5,804
Biguanides (SHHS2) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No 1,881 1,580 3,461
Yes 78 81 159
Unknown 260 200 460
Biguanides (SHHS2) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No - - - - - - -
Yes - - - - - - -
Unknown 4,907 515 11 88 280 3 5,804
Biguanides (SHHS2) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No 3,034 227 5 43 151 1 3,461
Yes 128 15 1 - 15 - 159
Unknown 425 14 2 5 14 - 460